[VRAX] QoQ Quarter Result on 30-Sep-2021 [#Q2]

Stock
[VRAX] Virax Biolabs Group Limited
Announcement Date
29-Sep-2021
Financial Year
2022
Quarter
30-Sep-2021 [#Q2]
Profit Trend
QoQ- -79.22%
YoY- -60.93%
Quarter Report
VRAX's Result
VRAX's Financial Summary
View:
Show?
Quarter Result
31/03/23 30/09/22 31/03/22 30/09/21 31/03/21 30/09/20 31/03/20 CAGR
Revenue 3 6 -93 0 110 14 25 -50.67%
PBT -4,004 -1,454 -1,175 -575 -283 -390 -185 178.68%
Tax -4,282 -1,451 17 -589 -249 -418 -8 711.93%
NP -4,014 -1,444 -1,156 -552 -308 -343 -177 183.05%
Tax Rate - - - - - - - -
Total Cost 4,017 1,449 1,064 552 417 357 202 170.92%
Ratio Analysis
31/03/23 30/09/22 31/03/22 30/09/21 31/03/21 30/09/20 31/03/20 CAGR
NP Margin -143,301.79 -25,062.69 1,245.26 0.00 -280.03 -2,453.26 -708.85 486.90%
Per Share
31/03/23 30/09/22 31/03/22 30/09/21 31/03/21 30/09/20 31/03/20 CAGR
EPS -2.58 -1.24 -1.02 -0.49 -0.27 -0.30 -0.02 405.27%
EPS Diluted -2.58 -1.24 -1.02 -0.49 -0.27 -0.30 -0.02 405.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.